334 related articles for article (PubMed ID: 25523883)
61. Blood plasma/IgG N-glycome biosignatures associated with major depressive disorder symptom severity and the antidepressant response.
Park DI; Štambuk J; Razdorov G; Pučić-Baković M; Martins-de-Souza D; Lauc G; Turck CW
Sci Rep; 2018 Jan; 8(1):179. PubMed ID: 29317657
[TBL] [Abstract][Full Text] [Related]
62. The effect of turmeric (Curcumin) supplementation on cytokine and inflammatory marker responses following 2 hours of endurance cycling.
Sciberras JN; Galloway SD; Fenech A; Grech G; Farrugia C; Duca D; Mifsud J
J Int Soc Sports Nutr; 2015; 12(1):5. PubMed ID: 25628521
[TBL] [Abstract][Full Text] [Related]
63. The Effect of a Dispersible Curcumin (HydroCurc®) Compared to a Placebo for Reducing Joint Pain in an Adult Population - A Randomised, Double-Blind Study.
Briskey D; Roche G; Rao A
Complement Med Res; 2022; 29(6):429-436. PubMed ID: 35477159
[TBL] [Abstract][Full Text] [Related]
64. Curcuminoids Lower Plasma Leptin Concentrations: A Meta-analysis.
Atkin SL; Katsiki N; Derosa G; Maffioli P; Sahebkar A
Phytother Res; 2017 Dec; 31(12):1836-1841. PubMed ID: 28880413
[TBL] [Abstract][Full Text] [Related]
65. A randomized, phase 1, placebo-controlled trial of APG-157 in oral cancer demonstrates systemic absorption and an inhibitory effect on cytokines and tumor-associated microbes.
Basak SK; Bera A; Yoon AJ; Morselli M; Jeong C; Tosevska A; Dong TS; Eklund M; Russ E; Nasser H; Lagishetty V; Guo R; Sajed D; Mudgal S; Mehta P; Avila L; Srivastava M; Faull K; Jacobs J; Pellegrini M; Shin DS; Srivatsan ES; Wang MB
Cancer; 2020 Apr; 126(8):1668-1682. PubMed ID: 32022261
[TBL] [Abstract][Full Text] [Related]
66. Aldosterone concentrations in saliva reflect the duration and severity of depressive episode in a sex dependent manner.
Segeda V; Izakova L; Hlavacova N; Bednarova A; Jezova D
J Psychiatr Res; 2017 Aug; 91():164-168. PubMed ID: 28477530
[TBL] [Abstract][Full Text] [Related]
67. Is Testosterone an Effective Hormonal Therapy for Women With Antidepressant-Resistant Major Depression?
Mathew SJ
Am J Psychiatry; 2020 Oct; 177(10):891-894. PubMed ID: 32998547
[No Abstract] [Full Text] [Related]
68. Co-Administration of Iron and Bioavailable Curcumin Reduces Levels of Systemic Markers of Inflammation and Oxidative Stress in a Placebo-Controlled Randomised Study.
Tiekou Lorinczova H; Begum G; Temouri L; Renshaw D; Zariwala MG
Nutrients; 2022 Feb; 14(3):. PubMed ID: 35277071
[TBL] [Abstract][Full Text] [Related]
69. Routinely accessible parameters of mineralocorticoid receptor function, depression subtypes and response prediction: a post-hoc analysis from the early medication change trial in major depressive disorder.
Engelmann J; Murck H; Wagner S; Zillich L; Streit F; Herzog DP; Braus DF; Tadic A; Lieb K; Műller MB
World J Biol Psychiatry; 2022 Oct; 23(8):631-642. PubMed ID: 34985381
[TBL] [Abstract][Full Text] [Related]
70. Using Epigenetic Tools to Investigate Antidepressant Response.
Fiori LM; Lin R; Ju C; Belzeaux R; Turecki G
Prog Mol Biol Transl Sci; 2018; 158():255-272. PubMed ID: 30072056
[TBL] [Abstract][Full Text] [Related]
71. The Effects of Curcumin on the Side Effects of Anticancer Drugs in Chemotherapy: A Randomized Controlled Trial.
Panahi Y; Vahedian-Azimi A; Saadat A; Togeh G; Rahimibashar F; Fetrat MK; Amirfakhrian H; Moallem SA; Majeed M; Sahebkar A
Adv Exp Med Biol; 2021; 1328():255-273. PubMed ID: 34981483
[TBL] [Abstract][Full Text] [Related]
72. Proteomics Approach for Biomarker Research in Major Depression: Antidepressant Effects.
Huang TL; Lo LH
Curr Drug Metab; 2018; 19(6):502-512. PubMed ID: 29623831
[TBL] [Abstract][Full Text] [Related]
73. Novel Form of Curcumin Improves Endothelial Function in Young, Healthy Individuals: A Double-Blind Placebo Controlled Study.
Oliver JM; Stoner L; Rowlands DS; Caldwell AR; Sanders E; Kreutzer A; Mitchell JB; Purpura M; Jäger R
J Nutr Metab; 2016; 2016():1089653. PubMed ID: 27630772
[TBL] [Abstract][Full Text] [Related]
74. [Curcumin as an ajuvant treatment of depression: mechanisms of action and application prospects].
Katasonov AB
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(2):125-131. PubMed ID: 32307422
[TBL] [Abstract][Full Text] [Related]
75. Cross-talk between systemic and cerebral inflammation in depressive disorders: Relevance to pathogenesis and treatment.
Viscogliosi G
Psychiatry Clin Neurosci; 2015 Aug; 69(8):506-7. PubMed ID: 25989949
[No Abstract] [Full Text] [Related]
76. Response to Letter About Memory and Brain Effects of Curcumin.
Siddarth P; Barrio JR; Small GW
Am J Geriatr Psychiatry; 2018 Jun; 26(6):716-717. PubMed ID: 29681520
[No Abstract] [Full Text] [Related]
77. Curcumin for Neuroprotection: Taking a Second Look at Results.
Dcruz MM; Mamidipalli SS; Thakurdesai A; Andrade C
Am J Geriatr Psychiatry; 2018 Jun; 26(6):715. PubMed ID: 29680181
[No Abstract] [Full Text] [Related]
78. Correction to "Efficacy and safety of curcumin in major depressive disorder: A randomized controlled trial".
Phytother Res; 2024 May; 38(5):2594. PubMed ID: 38507274
[No Abstract] [Full Text] [Related]
79. An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial.
Esmaily H; Sahebkar A; Iranshahi M; Ganjali S; Mohammadi A; Ferns G; Ghayour-Mobarhan M
Chin J Integr Med; 2015 May; 21(5):332-8. PubMed ID: 25776839
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
